Ganeden Biotech, Inc. v. American Brewing Company, Inc.
1:16-cv-00876
Overview
Parties
Defendant
B&R Liquid Adventure, LLC Operating Company
Represented By
0 Attorneys ListedAmerican Brewing Company, Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Ganeden Biotech, Inc. Operating Company
Represented By
2 Attorneys Listed1100 Skylight Office Tower
Ulmer & Berne - Cleveland, 1660 West Second Street
Ulmer & Berne - Cincinnati
Ulmer & Berne - Cincinnati, Ste. 2800
Court & Judges
Court
District Court, N.D. Ohio (ohnd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7713726
Inhibition of pathogens by probiotic bacteria
|
Filed: 2007-02-13
Issued: 2010-05-11
|
Expired (Term Ended)
Expires: 2021-07-31
|
|
|
US8697055
Probiotic, lactic acid-producing bacteria
|
Filed: 2012-03-19
Issued: 2014-04-15
|
Active (5.3 yrs remaining)
Expires: 2032-03-19
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).